A STUDY COMPARING ACUTE SIDE EFFECTS AND BREASTCOSMESIS IN EARLY STAGE BREAST CANCER PATIENTS RECEIVING SHORT COURSE RADIOTHERAPY VERSUS VERY SHORT COURSE RADIOTHERAPY

Phase 2

• Conditions: Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

• Registration Number: CTRI/2023/06/053665
• Lead Sponsor: I

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Histologically proven invasive carcinoma of the breast cT1-T2 N0-1M0 and cT3N0 AJCC stage 1 & 2 patients following complete excision of the primary tumour by breast conservation surgery. There should be adequate surgical resection of primary (ink negative) and nodal disease (negative sentinel lymph node biopsy or adequate axillary sampling or dissection (yield atleast 10 nodes).

2. Written informed consent

3. Age - 18 to 70 years

4. Female gender

5. ECOG Performance status 0 - 2

6. Non-metastatic disease.

Exclusion Criteria

1. Any histopathology other than invasive carcinoma and DCIS.

2. Synchronous or metachronous malignancy.

3. Pregnant or lactating women.

4. Uncontrolled concurrent illness like DM, HTN, tuberculosis.

5. Evidence of distant metastasis.

6. Recurrent or residual disease.

7. Previous history of radiation to thoracic and neck area.

8. Patients not meeting dose volume constraints.

Study & Design

• Study Type: Interventional
• Study Design: Not specified